Hedge Fund - EcoR1 Capital

The biopharma and life sciences hedge fund firm is betting big on companies whose stocks have plummeted after reporting bad news.

A decade ago, Marc Lasry, CEO and co-founder of distressed investor Avenue Capital Group, described in stark terms the impact of record low interest rates on the investment world.

New York - US regulators have rejected former White House communications director Anthony Scaramucci's hedge fund's filing to list a bitcoin exchange-traded fund.

Hedge-fund firms York Capital Management and Southpaw Asset Management are barring clients from getting back all of the money they have requested for year-end, a sign of the pressure that investors in...

Hedge fund manager and legendary trader Paul Tudor Jones has joined Bill Gates and Warren Buffett’s pledge to give more than half of his wealth away to charity.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA): Oleg Nodelman's EcoR1 Capital filed an amended 13D. You can check out EcoR1 Capital's latest holdings and filings here.

Immune Design Corp. (NASDAQ:IMDZ): Oleg Nodelman's EcoR1 Capital filed an amended 13D. You can check out EcoR1 Capital's latest holdings and filings here.

The Sohn and Next Wave Sohn Conferences took place in San Francisco last week, shining the spotlight on several growing and established hedge funds, who shared some of their best ideas with attendees.

aTyr Pharma Inc (NASDAQ:LIFE): Oleg Nodelman's EcoR1 Capital filed an amended 13D. You can check out EcoR1 Capital's latest holdings and filings here.